Clinical Trial: A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Advanced or Metastatic Solid Tumors
Study Type: INTERVENTIONAL
Official Title: A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Brief Summary:
The purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161.
Read more